News & Updates
Filter by Specialty:
Accelerated daratumumab infusion safe, well tolerated in multiple myeloma
29 May 2022
Accelerated administration of daratumumab, an anti-CD3 monoclonal antibody approved for multiple myeloma, is safe and well tolerated when given following at least two standard infusions, suggest the results of a recent study.
Accelerated daratumumab infusion safe, well tolerated in multiple myeloma
29 May 2022
COVID-19 jabs help reduce long-term symptoms
27 May 2022
byStephen Padilla
COVID-19 vaccination appears to reduce the odds of long COVID symptoms, with continuous improvement following a second dose, at least in the first few months after the shot, suggests a study.
